Development of MF-59 Adjuvant Using Chitosan Derivatives to Influenza Vaccine

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

LOGHMANI A.; Daldrezh N.; MOATTARI A.

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: JOURNAL OF ADVANCED BIOMEDICAL SCIENCES Year:2020 | Volume:10 | Issue:2 Page(s): 2261-2271

Download Full-Text

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Verion

View:

438

Download:

Cites:

Information Journal Paper

Title

Development of MF-59 Adjuvant Using Chitosan Derivatives to Influenza Vaccine

Author(s)

LOGHMANI A. | Daldrezh N. | MOATTARI A. | Issue Writer Certificate

Keywords

VaccineQ2

InfluenzaQ1

MF59Q1

Methylglycol-chitosanQ1

AdjuvantQ2

Abstract

Background & Objective: The Influenza virus causes hundreds of deaths in the world. Despite the availability of some authorized Vaccines for all age groups and its approved beneficial effects, the Influenza is still a major problem for public health. Materials & Methods: In this study, the Adjuvant of MF59 was developed by Methylglycol-chitosan. The physico-chemical characteristics and immune response stimulation of novel Adjuvant were measured in combination with the Influenza virus. Results: The new Adjuvant was produced with a nano-droplet diameter of 156 and Zeta potential of 29. The pH of Adjuvant was not significantly changed for two years. Immunization of mice with developed Adjuvant makes more HAI titer than MF59 Adjuvant. Conclusion: The favorable characteristics of physico-chemical properties and lack of local side effects of developed Adjuvant as well as its strong humoral immunity can introduce it as a novel MF59 Adjuvants.

Cites

No record.

References

Cite

APA: Copy

LOGHMANI, A., Daldrezh, N., & MOATTARI, A.. (2020). Development of MF-59 Adjuvant Using Chitosan Derivatives to Influenza Vaccine. JOURNAL OF ADVANCED BIOMEDICAL SCIENCES, 10(2 ), 2261-2271. SID. https://sid.ir/paper/369369/en

Vancouver: Copy

LOGHMANI A., Daldrezh N., MOATTARI A.. Development of MF-59 Adjuvant Using Chitosan Derivatives to Influenza Vaccine. JOURNAL OF ADVANCED BIOMEDICAL SCIENCES[Internet]. 2020;10(2 ):2261-2271. Available from: https://sid.ir/paper/369369/en

IEEE: Copy

A. LOGHMANI, N. Daldrezh, and A. MOATTARI, “Development of MF-59 Adjuvant Using Chitosan Derivatives to Influenza Vaccine,” JOURNAL OF ADVANCED BIOMEDICAL SCIENCES, vol. 10, no. 2 , pp. 2261–2271, 2020, [Online]. Available: https://sid.ir/paper/369369/en

Related Journal Papers